API response to Pfizer Australia announcement

API response to Pfizer Australia announcement

6 December 2010
ASX Announcement

Australian Pharmaceutical Industries Limited (API) has received notification from Pfizer Australia (Pfizer) that Pfizer intends to cease distributing its prescription medicines through wholesale distributors effective 31 January 2011. API is one of three wholesalers currently distributing Pfizer prescription products. Details of the Pfizer announcement can be found at pfizer.com.au/media


API is analysing the implications of this decision and further information will be provided as soon as practicable.

API contact
Stephen Roche
MD and CEO
(03)87203007

Suggested Articles

Look out, diabetes market: Novo Nordisk won its FDA nod for highly anticipated Rybelsus to control blood sugar in patients with Type 2 diabetes.

Insys is in fire sale mode as part of its bankruptcy plan, and now it’s been given the go-ahead to sell the opioid that helped get it there.

GSK CEO Emma Walmsley could soon have a new title: Microsoft board member. The software giant has nominated her to its board of directors.